Federal AndroGel Lawsuit Trials Discussed During MDL Status Conference, Bernstein Liebhard LLP Reports

August 17, 2015 - The federal court overseeing thousands of testosterone treatment lawsuits (http://www.testosteronelawsuithub.com/) convened its most recent Status Conference on August 14th, at which time competing proposals for the selection of AndroGel bellwether cases were reviewed. According to documents filed in the U.S. District Court, Northern District of Illinois, defendant AbbVie, Inc. has proposed that the Court select 32 AndroGel lawsuits for case specific discovery. Once discovery was completed, the parties would choose six lawsuits from that initial pool for trial. However, plaintiffs maintain that only the final six trial selections should be left up to Court, and have proposed that each side submit initial lists of 16 potential bellwether candidates. (In re: Testosterone Replacement Therapy Product Liability Litigation - MDL No. 2545)

"Our Firm is representing a number of plaintiffs in the federal testosterone litigation, and we look forward to the Court's decision in this matter. The selection of bellwether cases is an extremely important matter, as the outcomes of these trials could provide insight into how juries might decide similar AndroGel lawsuits," says Sandy A. Liebhard, a partner at Bernstein Liebhard LLP, a nationwide law firm representing victims of defective drugs and medical devices. The Firm continues to offer free case reviews to men who may have been harmed by low testosterone therapy medications.

Federal Testosterone Litigation
Court records indicate that more than 2,200 testosterone lawsuits have been filed in the Northern District of Illinois on behalf of men who allegedly suffered heart attacks and other cardiovascular events due to their use of AndroGel, Testim, Axiron and other prescription low-T medications. The litigation involving testosterone replacement therapy has been growing since January 2014, when the U.S. Food & Drug Administration (FDA) launched a safety review of the entire drug class. On March 3, 2015, the FDA ordered the manufacturers of prescription low-T treatments to update their labels with information regarding a potential association with an increased risk of heart attack and stroke. The agency also directed that the labels clearly state that the drugs have not been proven safe and effective for treating low testosterone related to male aging.

According to court documents, federal AndroGel lawsuits could begin going to trial next year. Bellwether trials involving other low-T treatments would likely begin sometime in 2017.

Men who were allegedly harmed by low testosterone therapy may be eligible to file their own claim in this litigation. To learn more about filing a testosterone treatment lawsuit, please visit Bernstein Liebhard LLP's website. Free, no-obligation legal consultations can be obtained by calling 800-511-5092.

About Bernstein Liebhard LLP
Bernstein Liebhard LLP is a New York-based law firm exclusively representing injured persons in complex individual and class action lawsuits nationwide since 1993. As a national law firm, Bernstein Liebhard LLP possesses all of the legal and financial resources required to successfully challenge billion dollar pharmaceutical and medical device companies. As a result, our attorneys and legal staff have been able to recover more than $3 billion on behalf of our clients. The Firm was named by The National Law Journal to the Plaintiffs' Hot List, recognizing the top plaintiffs firms in the country, for 12 consecutive years. Bernstein Liebhard LLP is the only firm in the country to be named to this prestigious list for a dozen consecutive years.

Bernstein Liebhard LLP
10 East 40th Street
New York, New York 10016
800-511-5092

ATTORNEY ADVERTISING. © 2015 Bernstein Liebhard LLP. The law firm responsible for this advertisement is Bernstein Liebhard LLP, 10 East 40th Street, New York, New York 10016, 800-511-5092. Prior results do not guarantee or predict a similar outcome with respect to any future matter.

Contact Information:
Sandy A. Liebhard, Esq.
Bernstein Liebhard LLP
info (at) consumerinjurylawyers (dot) com
http://www.testosteronelawsuithub.com/
https://plus.google.com/115936073311125306742?rel=author